ScholarIQanswers from OpenAlex

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics

PaperCitations, authors & open-access status

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics have?

ScholarIQcitation count

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics has 238 citations in the OpenAlex counts ScholarIQ stores.

When was Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics published?

ScholarIQyear

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics has 2021 year in the ScholarIQ index.

What is the open-access status of Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics?

ScholarIQoa status

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics has gold oa status in the ScholarIQ index.

What is the DOI of Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics?

ScholarIQdoi

The DOI for Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics is on the source record.

What is the PMID of Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics?

ScholarIQpmid

The PMID for Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics is on the source record.

What is the OpenAlex record for Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics?

ScholarIQopenalex

The OpenAlex for Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial